相关实验视频
Updated: Jun 21, 2025

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.4K
微RNA和Nrf2信号在人类癌症中的相互作用
Reza Panahizadeh1, Mohammad Amin Vatankhah1, Ali Safari1
1Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Cancer cell international
|July 5, 2024
概括
微RNAs (miRNAs) 调节Nrf2通路,影响癌症的发展和治疗. 了解miRNA-Rab相互作用对于克服基于miRNA的癌症治疗方面的挑战至关重要.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 微RNA (miRNA) 是一种非编码的RNA,可以在转录后调节基因表达.
- 核因子E2相关因子2 (Nrf2) 是抗氧化剂防御的关键,与癌症耐药性相关的失调.
- 拉斯关联结合 (Rab) 蛋白与囊泡运输和癌症发展有关.
研究的目的:
- 审查miRNAs在各种人类癌症中调节Nrf2通路中的作用.
- 探索miRNA-Rab相互作用在癌症治疗中的关键作用.
- 讨论开发基于miRNA的抗癌疗法的挑战和潜在方法.
主要方法:
- 关于miRNAs,Nrf2通路,Rab蛋白和癌症的科学文章的文献评论.
- 在癌症发病过程中分析miRNA介导的调节机制.
- 确定基于miRNA的癌症治疗方法的治疗策略和局限性.
主要成果:
- 毫米RNA显著调节Nrf2通路,影响癌症的发展和进展.
- 由于其在癌症治疗中的重要性,MiRNA-Rab相互作用越来越被认可.
- 目前对癌症中miRNA-Rab相互作用的理解仍然不完整.
结论:
- 在人类癌症中,MiRNAs是Nrf2通路的关键调节者.
- 向miRNA-Rab相互作用显示了治疗潜力,但面临着诸如交叉向和不稳定性等挑战.
- 需要进一步的研究来阐明miRNA-Rab相互作用,以开发有效的癌症治疗方法.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K

